• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Tobacco cessation treatment for people with schizophrenia].

作者信息

Papachristou Christos, Humair Jean-Paul

机构信息

Service de psychiatrie adulte, Hôpitaux universitaires de Genève, 1211 Genève 14.

Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.

出版信息

Rev Med Suisse. 2022 Jun 22;18(787):1275-1278. doi: 10.53738/REVMED.2022.18.787.1275.

DOI:10.53738/REVMED.2022.18.787.1275
PMID:35735153
Abstract

Among patients suffering from schizophrenia, tobacco smoking prevalence is extremely high and represents a major burden in terms of morbidity and mortality. Tobacco smoking is under-diagnosed and under-treated by mental health professionals, mostly due to an overestimated risk of jeopardizing the patient's mental condition, but also due to a lack of expertise on tobacco cessation treatment. Despite the extent of this problem, pharmacological approaches haven't been studied enough. However, treatments such as varenicline, bupropion and nicotine replacement are effective and well tolerated and their prescription should be recommended for tobacco withdrawal among these patients.

摘要

相似文献

1
[Tobacco cessation treatment for people with schizophrenia].
Rev Med Suisse. 2022 Jun 22;18(787):1275-1278. doi: 10.53738/REVMED.2022.18.787.1275.
2
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.青少年戒烟药物治疗的疗效和耐受性。
Paediatr Drugs. 2012 Apr 1;14(2):91-108. doi: 10.2165/11594370-000000000-00000.
3
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.
4
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.临床实践研究数据库中戒烟治疗与抑郁、自杀和自我伤害风险的前瞻性队列研究。
BMJ. 2013 Oct 11;347:f5704. doi: 10.1136/bmj.f5704.
5
[Stopping and reducing smoking in patients with schizophrenia].[精神分裂症患者戒烟与减少吸烟量]
Encephale. 2019 Sep;45(4):345-356. doi: 10.1016/j.encep.2019.04.067. Epub 2019 May 29.
6
Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.精神分裂症患者戒烟的药物治疗：系统评价。
Expert Opin Pharmacother. 2020 Apr;21(5):581-590. doi: 10.1080/14656566.2020.1721466. Epub 2020 Feb 3.
7
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
8
Varenicline: a first-line treatment option for smoking cessation.伐尼克兰：戒烟的一线治疗选择。
Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021.
9
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.伐仑克林：作为戒烟辅助药物的药物经济学评价。
Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000.
10
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.